Anthony L. Keller;Rodney L. Benjamin;Jeffrey Varelman
发明人:
Rodney L. Benjamin,Anthony L. Keller,Jeffrey Varelman
申请号：
US13458907
公开号：
US08546373B2
申请日:
2012.04.27
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Embodiments of the invention relate generally to formulations comprising methylsulfonylmethane (MSM) and one or more therapeutic agents, and uses of such formulations to treat, inhibit and/or sensitize infectious diseases. In several embodiments, such formulations are effective to treat, inhibit and/or sensitize drug-resistant bacterial microorganisms, for example, methicillin-resistant Staphylococcus aureus (MRSA).
